claim
The combination of cisplatin and a histone deacetylase inhibitor may synergistically suppress the progression of non-small cell lung cancer.
Authors
Sources
- Cellular rejuvenation: molecular mechanisms and potential ... - Nature www.nature.com via serper
Referenced by nodes (3)
- cisplatin concept
- non-small cell lung cancer concept
- histone deacetylase inhibitors concept